Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.

Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, Logan J, Franceschi D, Gatley J, Hitzemann R, Gifford A, Wong C, Pappas N.

Am J Psychiatry. 2001 Dec;158(12):2015-21.

PMID:
11729018
2.

Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction.

Volkow ND, Wang GJ, Fowler JS, Hitzemann R, Angrist B, Gatley SJ, Logan J, Ding YS, Pappas N.

Am J Psychiatry. 1999 Jan;156(1):19-26.

PMID:
9892293
3.

Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers.

London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, Shinn AK, Miotto K, Learn J, Dong Y, Matochik JA, Kurian V, Newton T, Woods R, Rawson R, Ling W.

Arch Gen Psychiatry. 2004 Jan;61(1):73-84.

PMID:
14706946
4.

Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.

Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, Dewey SL, Wolf AP.

Synapse. 1993 Jun;14(2):169-77.

PMID:
8101394
5.

Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography.

Iyo M, Nishio M, Itoh T, Fukuda H, Suzuki K, Yamasaki T, Fukui S, Tateno Y.

Psychiatry Res. 1993 Dec;50(4):217-31.

PMID:
8177922
6.

Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptoms.

Sekine Y, Minabe Y, Ouchi Y, Takei N, Iyo M, Nakamura K, Suzuki K, Tsukada H, Okada H, Yoshikawa E, Futatsubashi M, Mori N.

Am J Psychiatry. 2003 Sep;160(9):1699-701.

PMID:
12944350
7.

Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers.

Volkow ND, Chang L, Wang GJ, Fowler JS, Franceschi D, Sedler MJ, Gatley SJ, Hitzemann R, Ding YS, Wong C, Logan J.

Am J Psychiatry. 2001 Mar;158(3):383-9.

PMID:
11229978
8.

Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity.

Lee B, London ED, Poldrack RA, Farahi J, Nacca A, Monterosso JR, Mumford JA, Bokarius AV, Dahlbom M, Mukherjee J, Bilder RM, Brody AL, Mandelkern MA.

J Neurosci. 2009 Nov 25;29(47):14734-40. doi: 10.1523/JNEUROSCI.3765-09.2009.

9.

Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence.

Wang GJ, Volkow ND, Chang L, Miller E, Sedler M, Hitzemann R, Zhu W, Logan J, Ma Y, Fowler JS.

Am J Psychiatry. 2004 Feb;161(2):242-8.

PMID:
14754772
10.

Decreased dopamine activity predicts relapse in methamphetamine abusers.

Wang GJ, Smith L, Volkow ND, Telang F, Logan J, Tomasi D, Wong CT, Hoffman W, Jayne M, Alia-Klein N, Thanos P, Fowler JS.

Mol Psychiatry. 2012 Sep;17(9):918-25. doi: 10.1038/mp.2011.86. Epub 2011 Jul 12.

11.

Effects of methylphenidate on regional brain glucose metabolism in humans: relationship to dopamine D2 receptors.

Volkow ND, Wang GJ, Fowler JS, Logan J, Angrist B, Hitzemann R, Lieberman J, Pappas N.

Am J Psychiatry. 1997 Jan;154(1):50-5.

PMID:
8988958
12.

Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex.

Volkow ND, Fowler JS.

Cereb Cortex. 2000 Mar;10(3):318-25. Review.

PMID:
10731226
13.

Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography.

Sevy S, Smith GS, Ma Y, Dhawan V, Chaly T, Kingsley PB, Kumra S, Abdelmessih S, Eidelberg D.

Psychopharmacology (Berl). 2008 May;197(4):549-56. doi: 10.1007/s00213-008-1075-1. Epub 2008 Feb 13.

PMID:
18270689
14.

The orbitofrontal cortex in methamphetamine addiction: involvement in fear.

Goldstein RZ, Volkow ND, Chang L, Wang GJ, Fowler JS, Depue RA, Gur RC.

Neuroreport. 2002 Dec 3;13(17):2253-7.

15.

Striatal Dopamine D2/D3 Receptor Availability Is Associated with Executive Function in Healthy Controls but Not Methamphetamine Users.

Ballard ME, Dean AC, Mandelkern MA, London ED.

PLoS One. 2015 Dec 14;10(12):e0143510. doi: 10.1371/journal.pone.0143510. eCollection 2015.

16.

Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.

Volkow ND, Wang GJ, Smith L, Fowler JS, Telang F, Logan J, Tomasi D.

Neuroimage. 2015 Nov 1;121:20-8. doi: 10.1016/j.neuroimage.2015.07.035. Epub 2015 Jul 21.

PMID:
26208874
17.

Reduced sleep duration mediates decreases in striatal D2/D3 receptor availability in cocaine abusers.

Wiers CE, Shumay E, Cabrera E, Shokri-Kojori E, Gladwin TE, Skarda E, Cunningham SI, Kim SW, Wong TC, Tomasi D, Wang GJ, Volkow ND.

Transl Psychiatry. 2016 Mar 8;6:e752. doi: 10.1038/tp.2016.14.

18.

Striatal dopamine D2 receptor availability predicts the thalamic and medial prefrontal responses to reward in cocaine abusers three years later.

Asensio S, Romero MJ, Romero FJ, Wong C, Alia-Klein N, Tomasi D, Wang GJ, Telang F, Volkow ND, Goldstein RZ.

Synapse. 2010 May;64(5):397-402. doi: 10.1002/syn.20741.

19.

High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors.

Volkow ND, Wang GJ, Begleiter H, Porjesz B, Fowler JS, Telang F, Wong C, Ma Y, Logan J, Goldstein R, Alexoff D, Thanos PK.

Arch Gen Psychiatry. 2006 Sep;63(9):999-1008.

PMID:
16953002
20.

Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors.

Volkow ND, Wang GJ, Telang F, Fowler JS, Thanos PK, Logan J, Alexoff D, Ding YS, Wong C, Ma Y, Pradhan K.

Neuroimage. 2008 Oct 1;42(4):1537-43. doi: 10.1016/j.neuroimage.2008.06.002. Epub 2008 Jun 13.

Supplemental Content

Support Center